Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DAPTOMYCIN
- Preoperative Daptomycin Prophylaxis in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial
- Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
- FOUR-SIX TRIAL for the Treatment of Enterococcal Endocarditis
- Staphylococcus Aureus Network Adaptive Platform Trial
- Imipenem, Cilastatin Sodium, and Relebactam Monohydrate for the Treatment of Cancer Patients With Febrile Neutropenia
- DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia
- Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)
- Ceftriaxone as Home IV for Staph Infections
- Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With MSSA Bacteremia
- Post Implantation Syndrome and Administration on NSAIDs in Patients Undergoing EVAR for AAA
- Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)
- Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis
- Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
- Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
- Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia
- Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir
- IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB
- The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock
- Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection
- Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury
- A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial
- Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
- Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure
- Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin
- Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
- Pharmacokinetics Study of Intraperitoneal Administration of Daptomycin in Peritoneal Infection
- Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia
- Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
- Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
- Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
- Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection
- Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
- Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)
- Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia
- The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin
- Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2)
- Concentration of Antimicrobials in Catheter-lock Solutions
- Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
- Daptomycin in Pediatric Patients With Bacterial Meningitis
- Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia
- Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis
- Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
- Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs)
- Daptomycin Versus Placebo in Patients With Neutropenia and Fever
- Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study
- Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus
- Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment
- Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty
- Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
- Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections
- Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting
- Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration
- Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection
- Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens
- Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment
- Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections
- Cerebrospinal Fluid Pharmacokinetics of Daptomycin
- Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
- Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
- Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis
- An Open Label Study to Describe the Pharmacokinetics of Daptomycin in Infants
- Study to Evaluate Daptomycin Given During Dialysis and After Dialysis
- Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China
- China Registration Study in Patients With Skin Infections
- A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)
- Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
- Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery
- Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia
- PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections
- Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)
- Cubicin(R) for Complicated Post-surgical Wound Infections
- Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)
- A Pilot Study of Daptomycin for Antimicrobial Prophylaxis
- Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae
- Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia
- Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus
- Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)
- Catheter Related - Gram Positive Bloodstream Infections
- Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections
- Acute Renal Failure in the Surgical Intense Care Units - NTUH-SICU-ARF (NSARF) Study
- Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections
- Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci
- Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections
- Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.
- Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
- Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy
- Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
- Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections
- Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
- Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections
- Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus
- Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
Clinical trials list
click for details